US FDA User Fees: Lay-Off Notices Planned For Early September If Congress Doesn’t Pass Bill
Executive Summary
The notices normally would go out on 1 August, but unspent user fee funds may be able to sustain work for a few weeks if the program expires.
You may also be interested in...
‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms
Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.
US FDA User Fee Legislation: Is Sen. Burr’s ‘Clean’ Bill A Lifeline – Or A Wrench In The Works?
Sen. Richard Burr introduces a reauthorization bill without any policy changes, even ones he previously endorsed, saying it’s the clearest path forward now.
US FDA Commissioner Califf Expects To Leave Post Following 2024 Elections
Outlining what changes he wants to see at the agency before he leaves, Califf also worries congressional inaction on the user fee reauthorization could affect hiring efforts.